The Impact of Treatment Choice on Long-term Outcomes in Older Adults with Primary Hyperparathyroidism

治疗选择对患有原发性甲状旁腺功能亢进症的老年人长期预后的影响

基本信息

  • 批准号:
    9751150
  • 负责人:
  • 金额:
    $ 11.74万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-08-01 至 2021-07-31
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract Primary hyperparathyroidism (PHPT) is a common endocrine disorder that predominantly affects patients older than 60 and is increasing in prevalence. Population-based data on long-term outcomes for geriatric patients who undergo parathyroidectomy or observation with medical management are lacking. Understanding which older adults will benefit from medical vs. surgical management will help reduce the burden of the late complications of PHPT, without exposing elders who will not benefit to the risks of surgery. Our long-term goal is to devise evidence-based guidelines to optimally manage older adults with PHPT with parathyroidectomy or medical therapy to reduce morbidity, functional and cognitive decline, and mortality. The overall objective of this proposed study is to quantify the impact of parathyroidectomy on the risk of subsequent fracture and major adverse cardiovascular (CV) events in older adults with PHPT, and to identify risk factors for morbidity with medical and surgical management. Our central hypothesis is that older adults with PHPT who undergo parathyroidectomy experience fewer fractures and major adverse CV events than those who do not undergo surgery, and that patient factors associated with adverse outcomes in both treatment groups can be identified and used to guide patient selection for surgery. This hypothesis will be tested using longitudinal analysis of Medicare claims data to identify a nationally representative cohort of patients with PHPT and a control cohort without PHPT to pursue two specific aims: 1) Identify factors associated with the surgical management of PHPT in older adults in the United States; and 2) Compare the 5-year incidence of and risk factors for new fractures or major adverse CV events in older adults with PHPT undergoing parathyroidectomy vs. medical management and determine the relationship between patient characteristics and adverse outcomes. This project is innovative because it will be the first study to examine the long-term outcomes of parathyroidectomy vs. medical management for PHPT in a national population older than 65 in the United States, and the first study to look at the management of PHPT in Medicare beneficiaries. The proposed research is significant because it will provide benchmark data on the long-term outcomes for geriatric patients with PHPT who undergo parathyroidectomy vs. medical management and greatly enhance our understanding of geriatric- specific predictors of adverse outcomes in the management of PHPT.
项目摘要/摘要 原发性甲状旁腺功能亢进症(PHPT)是一种常见的内分泌疾病,主要影响老年患者 超过60岁,而且患病率正在上升。老年患者长期预后的基于人群的数据 缺乏接受甲状旁腺切除术或接受内科治疗的观察者。了解哪些内容 老年人将受益于内科和外科治疗,这将有助于减轻老年人的负担 PHPT的并发症,而不会暴露老年人谁不会受益于手术的风险。我们的长期目标 是设计基于证据的指南,以最佳方式处理老年甲状旁腺切除术或甲状旁腺切除术的老年人 减少发病率、功能和认知能力下降以及死亡率的药物治疗。总的目标是 这项拟议的研究旨在量化甲状旁腺切除术对继发骨折和主要 老年PHPT患者的心血管不良事件,并确定发病率的危险因素 内科和外科管理。我们的中心假设是患有PHPT的老年人 与未行甲状旁腺切除术的患者相比,行甲状旁腺切除术的患者骨折和主要不良心血管事件较少。 手术,并且两个治疗组中与不良结果相关的患者因素都可以确定 并用于指导手术患者的选择。这一假设将通过以下纵向分析进行检验 联邦医疗保险声称有数据来确定具有全国代表性的PHPT患者队列和对照队列 在没有PHPT的情况下实现两个具体目标:1)确定与手术治疗相关的因素 美国老年人中的PHPT;以及2)比较新发病的5年发病率和危险因素 接受甲状旁腺切除术的老年PHPT患者的骨折或主要不良心血管事件与内科治疗相比 管理,并确定患者特征和不良后果之间的关系。这 该项目具有创新性,因为它将是第一个研究甲状旁腺切除术的长期结果的研究 美国65岁以上人口对PHPT的医疗管理,也是第一个 研究如何在医疗保险受益人中管理PHPT。这项拟议的研究具有重要意义 因为它将为患有PHPT的老年患者提供长期预后的基准数据 接受甲状旁腺切除术与内科治疗相比,大大提高了我们对老年人的认识- PHPT管理中不良后果的特定预测因素。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Racial disparities in the utilization of parathyroidectomy among patients with primary hyperparathyroidism: Evidence from a nationwide analysis of Medicare claims.
  • DOI:
    10.1016/j.surg.2021.05.037
  • 发表时间:
    2022-01
  • 期刊:
  • 影响因子:
    3.8
  • 作者:
    Alobuia WM;Meng T;Cisco RM;Lin DT;Suh I;Tamura MK;Trickey AW;Kebebew E;Seib CD
  • 通讯作者:
    Seib CD
Reducing Opioid Use in Endocrine Surgery Through Patient Education and Provider Prescribing Patterns.
通过患者教育和提供者处方模式减少内分泌手术中阿片类药物的使用。
  • DOI:
    10.1016/j.jss.2020.06.025
  • 发表时间:
    2020-12
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kwan SY;Lancaster E;Dixit A;Inglis-Arkell C;Manuel S;Suh I;Shen WT;Seib CD
  • 通讯作者:
    Seib CD
Ensemble machine learning for the prediction of patient-level outcomes following thyroidectomy.
甲状腺切除术后患者水平结局的预测的集合机器学习。
  • DOI:
    10.1016/j.amjsurg.2020.11.055
  • 发表时间:
    2021-08
  • 期刊:
  • 影响因子:
    3
  • 作者:
    Seib CD;Roose JP;Hubbard AE;Suh I
  • 通讯作者:
    Suh I
Undertreatment of primary hyperparathyroidism in a privately insured US population: Decreasing utilization of parathyroidectomy despite expanding surgical guidelines.
  • DOI:
    10.1016/j.surg.2020.04.066
  • 发表时间:
    2021-01
  • 期刊:
  • 影响因子:
    3.8
  • 作者:
    Seib CD;Meng T;Suh I;Cisco RM;Lin DT;Morris AM;Trickey AW;Kebebew E
  • 通讯作者:
    Kebebew E
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Carolyn Dacey Seib其他文献

Carolyn Dacey Seib的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Carolyn Dacey Seib', 18)}}的其他基金

Developing a framework to individualize surgical decision-making for older adults with primary hyperparathyroidism
开发一个框架,为患有原发性甲状旁腺功能亢进症的老年人提供个性化的手术决策
  • 批准号:
    10337961
  • 财政年份:
    2021
  • 资助金额:
    $ 11.74万
  • 项目类别:
Developing a framework to individualize surgical decision-making for older adults with primary hyperparathyroidism
开发一个框架,为患有原发性甲状旁腺功能亢进症的老年人提供个性化的手术决策
  • 批准号:
    10493450
  • 财政年份:
    2021
  • 资助金额:
    $ 11.74万
  • 项目类别:
Developing a framework to individualize surgical decision-making for older adults with primary hyperparathyroidism
开发一个框架,为患有原发性甲状旁腺功能亢进症的老年人提供个性化的手术决策
  • 批准号:
    10661770
  • 财政年份:
    2021
  • 资助金额:
    $ 11.74万
  • 项目类别:

相似海外基金

Optimizing Health and Well-Being of Diverse Mothers with IDD and Their Infants During the Perinatal Period: A Virtual Advocate Tool for Data-Driven Supports
优化患有 IDD 的不同母亲及其婴儿在围产期的健康和福祉:用于数据驱动支持的虚拟倡导工具
  • 批准号:
    10760051
  • 财政年份:
    2023
  • 资助金额:
    $ 11.74万
  • 项目类别:
POSE: Phase II: Advocate Led Long-term Gameplan for Open OnDemand (ALL GOOD)
POSE:第二阶段:倡导者主导 Open OnDemand 的长期游戏计划(一切顺利)
  • 批准号:
    2303692
  • 财政年份:
    2023
  • 资助金额:
    $ 11.74万
  • 项目类别:
    Standard Grant
Capitalising on our differences: A gathering to better understand and advocate for Early Career Health Researchers in Canada
利用我们的差异:更好地理解和倡导加拿大早期职业健康研究人员的聚会
  • 批准号:
    468168
  • 财政年份:
    2022
  • 资助金额:
    $ 11.74万
  • 项目类别:
    Miscellaneous Programs
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
  • 批准号:
    10427960
  • 财政年份:
    2022
  • 资助金额:
    $ 11.74万
  • 项目类别:
Evaluating an ACEs-Targeting Advocate Model of a Substance Use Prevention Program
评估药物使用预防计划的针对 ACE 的倡导者模型
  • 批准号:
    10577074
  • 财政年份:
    2022
  • 资助金额:
    $ 11.74万
  • 项目类别:
The Art of Creation: Using Art-Based Knowledge Translation to Promote and Advocate for a Healthy Start to Life
创造的艺术:利用基于艺术的知识转化来促进和倡导健康的生命开端
  • 批准号:
    486588
  • 财政年份:
    2022
  • 资助金额:
    $ 11.74万
  • 项目类别:
    Studentship Programs
When I am Old, I shall Wear Purple Nail Varnish: Utilising performance art to construct queer spaces that celebrate and advocate for ageing bodies
当我老了,我要涂紫色指甲油:利用行为艺术构建酷儿空间,庆祝和倡导衰老的身体
  • 批准号:
    2760091
  • 财政年份:
    2022
  • 资助金额:
    $ 11.74万
  • 项目类别:
    Studentship
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
  • 批准号:
    10621188
  • 财政年份:
    2022
  • 资助金额:
    $ 11.74万
  • 项目类别:
Techquity by FAITH!: A cluster randomized controlled trial to assess the efficacy of a community-informed, cardiovascular health promotion mobile hlth intervention with digital health advocate support
Techquity by FAITH!:一项整群随机对照试验,旨在评估社区知情、心血管健康促进移动 hlth 干预措施在数字健康倡导者支持下的效果
  • 批准号:
    10891016
  • 财政年份:
    2021
  • 资助金额:
    $ 11.74万
  • 项目类别:
CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D
自身抗体阳性受试者的 CMV 反应主张抗病毒治疗以预防 T1D
  • 批准号:
    10230365
  • 财政年份:
    2020
  • 资助金额:
    $ 11.74万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了